We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
Up-to-date travel health information written for health care professionals
Become a Travax member25 March 2024
A live, attenuated (weakened) dengue vaccine called Qdenga® is licensed in the United Kingdom (UK). The Joint Committee on Vaccination and Immunisation (JCVI) Travel Sub-Committee (TSC) has reviewed the vaccine information and the minutes of their meeting and the main JCVI meeting are now available on the JCVI website. The JCVI has recommended that the following groups could be offered the Qdenga® vaccine: Individuals aged 4 years of age and older with confirmed dengue infection in the past who ... View Full Article
14 March 2024
The UK Health Security Agency recently published updated guidance on yellow fever (YF) vaccination in ...View Full Article
19 February 2024
Please be advised that until the end of March 2024, the TRAVAX health professional advice line will only ...View Full Article
07 February 2024
The Green Book Chapter on yellow fever has been updated as of 6 February 2024. Public Health Scotland ...View Full Article
15 January 2024
The World Health Organization (WHO) certified Cape Verde as malaria-free on 12 January 2024. Cape Verde ...View Full Article
Information
Yellow Fever, Green Book Chapter and Pre-vaccination Checklist Update
Information
The TRAVAX health professional advice line will only be available on Monday afternoons from 2-3pm.
Information
Advice on supply constraints of rabies vaccine....